C12Y 106/05
Oxidoreductases acting on nadh or nadph: with a quinone or similar compound
Official title: with a quinone or similar compound as acceptor (1.6.5)
C12Y106/05 (Oxidoreductases acting on nadh or nadph: with a quinone or similar compound) appears on 33 US grants and 51 published applications in this corpus.
Search patents in C12Y- Granted patents
- 33
- Published applications
- 51
- Assignees
- 31
- Inventors
- 101
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 4 |
| 2015 | 1 | 2 |
| 2016 | 1 | 2 |
| 2017 | 1 | 5 |
| 2018 | 3 | 0 |
| 2019 | 2 | 2 |
| 2020 | 2 | 2 |
| 2021 | 3 | 4 |
| 2022 | 3 | 10 |
| 2023 | 1 | 4 |
| 2024 | 2 | 4 |
| 2025 | 6 | 0 |
| 2026 | 6 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 106/05002Nadh dehydrogenase12
- C12Y 106/05003Nadh dehydrogenase11
- C12Y 106/05005Nadph:quinone reductase5
- C12Y 106/05009Nadh:ubiquinone reductase5
- C12Y 106/0501Nadph dehydrogenase1
- C12Y 106/05004Monodehydroascorbate reductase0
- C12Y 106/05006P-benzoquinone reductase0
- C12Y 106/050072-hydroxy-1,4-benzoquinone reductase0
All 9 subgroupsShow fewer
Recent patents
- NAD(P)- dependent responsive enzymes, electrodes and sensors, and methods for making and using the same4 Aug 2026US 12,698,517 B2Abbott Diabetes Care Inc.
- NAD(P)-dependent responsive enzymes, electrodes and sensors, and methods for making and using the same21 Jul 2026US 12,686,881 B2Abbott Diabetes Care Inc.
- NAD(P)- dependent responsive enzymes, electrodes and sensors, and methods for making and using the same21 Jul 2026US 12,686,882 B2Abbott Diabetes Care Inc.
- Microorganisms and methods for increasing co-factors17 Mar 2026US 12,577,591 B2Genomatica, Inc.
- NAD(P)-dependent responsive enzymes, electrodes and sensors, and methods for making and using the same17 Mar 2026US 12,577,603 B2Abbott Diabetes Care Inc.
- Recombinant microorganism with regulated activity of manganese import protein and method for producing o-phosphoserine, cysteine or cysteine derivatives using the same6 Aug 2026US 2026/0226406 A1Cj Cheiljedang Corporation
- Engineered mesenchymal stem cell and use thereof14 May 2026US 2026/0130944 A1Tsinghua University
- Production of chemicals from renewable sources8 Jan 2026US 2026/0009056 A1Zymochem, Inc.
- Nad(p)- dependent responsive enzymes, electrodes and sensors, and methods for making and using the same1 Jan 2026US 2026/0002188 A1Abbott Diabetes Care Inc.
- Nad(p)- dependent responsive enzymes, electrodes and sensors, and methods for making and using the same1 Jan 2026US 2026/0002189 A1Abbott Diabetes Care Inc.
Most cited
By later US patents
- NAD(P)- dependent responsive enzymes, electrodes and sensors, and methods for making and using the same17US 11,091,788 B2Abbott Diabetes Care Inc. · 2021
- Methods for improving cognitive function via modulation of quinone reductase 24US 10,113,171 B2Carmel-Haifa University Economic Corp. Ltd. · 2018
- Methods for improving cognitive function via modulation of quinone reductase 24US 10,676,747 B2Carmel-Haifa University Economic Corp. Ltd. · 2020
- Production of chemicals from renewable sources2US 11,692,208 B2Zymochem, Inc. · 2023
- Acid-tolerant yeast cell, method of producing organic acid using the same, and method of producing the yeast cell1US 10,053,714 B2Samsung Electronics Co., Ltd. · 2018